Latest updates for Cldx

Fresh curated links around CLDX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Celldex: 'Strong Buy' Barzolvolimab Carries To Q4 2026 CSU Data Readouts
  • Arcus: 'Buy' On Casdatifan Late-Stage CcRCC Advancement And 1st-Line Expansions
  • CDT Equity enters SAFE investment with Pep'd to expand U.S. peptide market footprint

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /1 month ago

Celldex: 'Strong Buy' Barzolvolimab Carries To Q4 2026 CSU Data Readouts

Read source
seekingalpha.com /1 month ago

Arcus: 'Buy' On Casdatifan Late-Stage CcRCC Advancement And 1st-Line Expansions

Read source
seekingalpha.com /2 weeks ago

CDT Equity enters SAFE investment with Pep'd to expand U.S. peptide market footprint

Read source
roi-nj.com /1 month ago

Citius Oncology of Cranford says commercial response to cancer treatment is strong

Citius Oncology Inc., an oncology‑focused biopharmaceutical company and majority‑owned subsidiary of Citius Pharmaceuticals Inc., provided an update Aug. 5 on the expanding base of...

Read source
seekingalpha.com /3 weeks ago

CSL Limited (CSLLY) Q4 2026 Earnings Call Transcript

Read source
seekingalpha.com /1 month ago

COPT Defense Properties (CDP) Q2 2026 Earnings Call Transcript

Read source
multiple-sclerosis-research.org /1 month ago

Clad-Labs (Part 10)

Let’s find the CLAD-LADS to see who uses cladribine 10mg tablets in their clinics. So the inclusion is count the places that use cladribine tablets and assess the total number of t...

Read source
seekingalpha.com /1 month ago

Dynex Capital, Inc. (DX) Q2 2026 Earnings Call Transcript

Read source
cafepharma.com /6 days ago

LVL

LVL Anonymous (not verified) Thu, 09/03/2026 - 12:46 field_thread_url https://cafepharma.com/boards/threads/lvl.715758/ board name...

Read source
cafepharma.com /1 month ago

Syndax

Syndax Anonymous (not verified) Sun, 07/19/2026 - 15:19 field_thread_url https://cafepharma.com/boards/threads/syndax.695213/ board name...

Read source
fool.com /3 weeks ago

CareCloud (CCLD) Q2 2026 Earnings Call Transcript

Revenue grew 16% to $31.9 million as recurring tech revenue climbed to 75% of total.

Read source
seekingalpha.com /1 month ago

A Deeper Dive Into Design Therapeutics

Read source
seekingalpha.com /3 weeks ago

Celcuity plans late Q3 2026 REVTORPYK shipments and targets sNDA submission in Q3 2026

Read source
seekingalpha.com /1 month ago

DLH Holdings Corp. 2026 Q3 - Results - Earnings Call Presentation

Read source
cafepharma.com /3 weeks ago

Lantheus Medical Imaging

Lantheus Medical Imaging Anonymous (not verified) Sun, 08/16/2026 - 03:35 field_thread_url https://cafepharma.com/boards/threads/lantheus-medical-imaging.4...

Read source
seekingalpha.com /1 month ago

Landis+Gyr Group AG (LDGYY) Q1 2027 Sales/ Trading Statement Call - Slideshow

Read source
seekingalpha.com /1 month ago

Nova Eye Medical Limited (ELXMF) Q4 2026 Earnings Call Transcript

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Cldx

seekingalpha.com

Recent coverage from public sources
Public source

cafepharma.com

Recent coverage from public sources
Public source

multiple-sclerosis-research.org

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

fool.com

Recent coverage from public sources
Public source